Spots Global Cancer Trial Database for brain tumor, recurrent
Every month we try and update this database with for brain tumor, recurrent cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Methotrexate Infusion Into Fourth Ventricle in Children With Recurrent Malignant Fourth Ventricular Brain Tumors | NCT02458339 | Brain Tumor, Re... Malignant Neopl... | Ommaya Reservoi... Methotrexate | 1 Year - 21 Years | The University of Texas Health Science Center, Houston | |
| Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT) | NCT05634707 | Primary Brain T... Brain Tumor, Re... | Fluoxetine Temozolomide | 24 Years - | Duke University | |
| T Cells Expressing HER2-specific Chimeric Antigen Receptors(CAR) for Patients With HER2-Positive CNS Tumors | NCT02442297 | Brain Tumor, Re... Brain Tumor, Re... | HER2-specific T... | 3 Years - | Baylor College of Medicine | |
| Methotrexate Infusion Into Fourth Ventricle in Children With Recurrent Malignant Fourth Ventricular Brain Tumors | NCT02458339 | Brain Tumor, Re... Malignant Neopl... | Ommaya Reservoi... Methotrexate | 1 Year - 21 Years | The University of Texas Health Science Center, Houston | |
| Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer | NCT01048008 | Advanced Cancer Brain Involveme... | DM-CHOC-PEN | 18 Years - | DEKK-TEC, Inc. | |
| Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer" | NCT01976910 | Advanced Cancer | DM-CHOC-PEN | 18 Years - | DEKK-TEC, Inc. | |
| Performance of Elucirem® in DSC-MRI Perfusion of Brain Gliomas | NCT06057168 | Brain Tumor, Pr... Brain Tumor, Re... | Elucirem Dotarem | 18 Years - | Guerbet | |
| Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers | NCT00141765 | Wilms Tumor Fibrosarcoma Carcinoma, Roun... Nasopharyngeal ... Brain Tumor, Re... | Myeloablative C... Stem Cell Rescu... | - 21 Years | University of Michigan Rogel Cancer Center | |
| Two-Part Study to Evaluate the Safety and Efficacy of Image Guided Surgery Using Indocyanine Green for Intramolecular Imaging of Nervous System Tumors Compared to Standard of Care, (TumorGlow) | NCT03262636 | Brain Tumor, Pr... Brain Tumor, Re... | Indocyanine Gre... | 18 Years - | University of Pennsylvania | |
| More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery | NCT01445691 | Benign Neoplasm... Brain Cancer Brain Neoplasms... Brain Neoplasms... Brain Tumor, Pr... Brain Tumor, Re... Brain Tumors Intracranial Ne... Neoplasms, Brai... Neoplasms, Intr... Primary Brain N... Primary Maligna... Primary Maligna... Gliomas Glioblastoma | 5-ALA (Gliolan) | 18 Years - 80 Years | Icahn School of Medicine at Mount Sinai | |
| Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA | NCT02800486 | Glioblastoma Anaplastic Astr... Anaplastic Olig... Glioma Brain Neoplasm Brain Cancer Brain Tumor Brain Tumor, Re... Brain Neoplasm,... | Intra-arterial ... Intra-arterial ... Hypofractionate... | 18 Years - | Northwell Health | |
| Neurosurgical Transitional Care Programme | NCT03593330 | Surgery Brain Tumor Brain Tumor, Re... Brain Pathology Spinal Diseases Spinal Stenosis Spinal Fusion Trigeminal Neur... Hydrocephalus Fusion of Spine Aneurysm SPINAL Fracture Chiari; Net Skull Injuries Brain Cancer Brain Metastase... Brain Diseases Brain Lesion Brain Cyst Spinal Curvatur... Spinal Instabil... Spinal Cord Neo... | Transitional Ca... | - | Barts & The London NHS Trust | |
| Two-Part Study to Evaluate the Safety and Efficacy of Image Guided Surgery Using Indocyanine Green for Intramolecular Imaging of Nervous System Tumors Compared to Standard of Care, (TumorGlow) | NCT03262636 | Brain Tumor, Pr... Brain Tumor, Re... | Indocyanine Gre... | 18 Years - | University of Pennsylvania | |
| A Phase I/II Study of the Photon Radiosurgery System | NCT00179907 | Brain Tumor, Re... Glioblastoma Mu... | Photon Radiosur... | 2 Years - 32 Years | Ann & Robert H Lurie Children's Hospital of Chicago | |
| Abemaciclib in Children With DIPG or Recurrent/Refractory Solid Tumors | NCT02644460 | Diffuse Intrins... Brain Tumor, Re... Solid Tumor, Re... Neuroblastoma, ... Ewing Sarcoma, ... Rhabdomyosarcom... Osteosarcoma, R... Rhabdoid Tumor,... | Abemaciclib | 2 Years - 25 Years | Emory University | |
| Methotrexate Infusion Into Fourth Ventricle in Children With Recurrent Malignant Fourth Ventricular Brain Tumors | NCT02458339 | Brain Tumor, Re... Malignant Neopl... | Ommaya Reservoi... Methotrexate | 1 Year - 21 Years | The University of Texas Health Science Center, Houston | |
| Vegetative Monitoring During Brainstem-associated Surgery | NCT03666507 | Brain Tumor, Re... Vestibular Schw... Brainstem Neopl... Brainstem Gliom... | Intraoperative ... | - | University Hospital Tuebingen | |
| Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors | NCT00747253 | Brain Tumor Brain Tumor, Re... Brain Neoplasm Brain Cancer Glioblastoma Mu... Recurrent Gliob... | AutoLITT system | 18 Years - | Monteris Medical | |
| Multimodality MRI and Liquid Biopsy in GBM | NCT04776980 | Glioblastoma Mu... Brain Tumor, Ad... Brain Tumor, Re... Brain Tumor, Pr... | Post Feraheme I... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors | NCT02457845 | Supratentorial ... Malignant Gliom... Glioblastoma Anaplastic Astr... PNET Cerebral Primit... Embryonal Tumor | G207 | 3 Years - 18 Years | University of Alabama at Birmingham | |
| Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT. | NCT01520870 | Glioblastoma Brain Tumor, Re... | PF-299804 (Daco... | 18 Years - | Grupo Español de Investigación en Neurooncología | |
| Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas | NCT01966809 | Brain Tumor, Re... | Photofrin photo... | 18 Years - | Medical College of Wisconsin | |
| Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer | NCT01048008 | Advanced Cancer Brain Involveme... | DM-CHOC-PEN | 18 Years - | DEKK-TEC, Inc. | |
| D2C7 for Adult Patients With Recurrent Malignant Glioma | NCT02303678 | Malignant Gliom... Brain Tumor, Re... | D2C7-IT | 18 Years - | Duke University | |
| Performance of Elucirem® in DSC-MRI Perfusion of Brain Gliomas | NCT06057168 | Brain Tumor, Pr... Brain Tumor, Re... | Elucirem Dotarem | 18 Years - | Guerbet | |
| Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors | NCT01682746 | Brain Tumor, Re... | Photofrin (porf... | 6 Months - 18 Years | Medical College of Wisconsin | |
| Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors | NCT01682746 | Brain Tumor, Re... | Photofrin (porf... | 6 Months - 18 Years | Medical College of Wisconsin | |
| Neurosurgical Transitional Care Programme | NCT03593330 | Surgery Brain Tumor Brain Tumor, Re... Brain Pathology Spinal Diseases Spinal Stenosis Spinal Fusion Trigeminal Neur... Hydrocephalus Fusion of Spine Aneurysm SPINAL Fracture Chiari; Net Skull Injuries Brain Cancer Brain Metastase... Brain Diseases Brain Lesion Brain Cyst Spinal Curvatur... Spinal Instabil... Spinal Cord Neo... | Transitional Ca... | - | Barts & The London NHS Trust | |
| Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors | NCT01682746 | Brain Tumor, Re... | Photofrin (porf... | 6 Months - 18 Years | Medical College of Wisconsin | |
| Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT. | NCT01520870 | Glioblastoma Brain Tumor, Re... | PF-299804 (Daco... | 18 Years - | Grupo Español de Investigación en Neurooncología | |
| Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA | NCT02800486 | Glioblastoma Anaplastic Astr... Anaplastic Olig... Glioma Brain Neoplasm Brain Cancer Brain Tumor Brain Tumor, Re... Brain Neoplasm,... | Intra-arterial ... Intra-arterial ... Hypofractionate... | 18 Years - | Northwell Health | |
| Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles) | NCT04427384 | Brain Tumor, Re... Brain Tumor Brain Tumor, Pr... Brain Tumor - M... Brain Tumor, Ad... Brain Tumor, Ad... | GammaTile | - | GT Medical Technologies, Inc. | |
| Performance of Elucirem® in DSC-MRI Perfusion of Brain Gliomas | NCT06057168 | Brain Tumor, Pr... Brain Tumor, Re... | Elucirem Dotarem | 18 Years - | Guerbet |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
